Ling L. Chen

Xiangya Road 110
Changsha, 410078, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Single-cell multiomics identifies an ALDH9A1-carnitine signaling axis driving resistance of NSCLC to immunotherapy.

Single-cell multiomics identifies an ALDH9A1-carnitine signaling axis driving resistance of NSCLC to immunotherapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 10, 2026

Targeting the β2-adrenergic receptor suppresses melanoma progression by disrupting the PKA-SOX10-MAGEA1 oncogenic axis.

Targeting the β2-adrenergic receptor suppresses melanoma progression by disrupting the PKA-SOX10-MAGEA1 oncogenic axis.

Journal: Biochemical pharmacology

Published: June 15, 2026

RPLP0 identified as a ferroptosis regulator in HCC through pan-cancer analysis.

RPLP0 identified as a ferroptosis regulator in HCC through pan-cancer analysis.

Journal: Frontiers in oncology

Published: May 26, 2026

Toward Smart VR Education in Media Production: Integrating AI into Human-Centered and Interactive Learning Systems.

Toward Smart VR Education in Media Production: Integrating AI into Human-Centered and Interactive Learning Systems.

Journal: Biomimetics (Basel, Switzerland)

Published: November 25, 2025

Research on team efficacy in CBA games based on complex network theory.

Research on team efficacy in CBA games based on complex network theory.

Journal: PloS one

Published: October 27, 2025

Discovery of a novel napabucasin derivative B16 as a potent STAT3 inhibitor for the treatment of triple-negative breast cancer.

Discovery of a novel napabucasin derivative B16 as a potent STAT3 inhibitor for the treatment of triple-negative breast cancer.

Journal: European journal of medicinal chemistry

Published: August 02, 2025

ARID1A Mediates SWI/SNF-Independent Maintenance of Heterochromatin Architecture to Restrain Viral Mimicry and Immunogenicity in Colon Cancer.

ARID1A Mediates SWI/SNF-Independent Maintenance of Heterochromatin Architecture to Restrain Viral Mimicry and Immunogenicity in Colon Cancer.

Journal: Cancer research

Published: July 23, 2025

Targeting of Gpx8-CSF1 axis resets the immune milieu of lung tumor and overcomes resistance to anti-PD-1 therapy.

Targeting of Gpx8-CSF1 axis resets the immune milieu of lung tumor and overcomes resistance to anti-PD-1 therapy.

Journal: Cell death and differentiation

Published: July 15, 2025

Discovery of a Novel Silybin Derivative for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Discovery of a Novel Silybin Derivative for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Journal: Journal of medicinal chemistry

Published: June 10, 2025

Pharmacokinetic-pharmacodynamic target attainment analyses as support for meropenem dosing regimens in critically ill adult and elderly patients with Pseudomonas aeruginosa infections.

Pharmacokinetic-pharmacodynamic target attainment analyses as support for meropenem dosing regimens in critically ill adult and elderly patients with Pseudomonas aeruginosa infections.

Journal: Frontiers in pharmacology

Published: June 09, 2025

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

Journal: Acta biochimica et biophysica Sinica

Published: May 31, 2025

ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function.

ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function.

Journal: Journal for immunotherapy of cancer

Published: May 24, 2025

Showing 1-12 of 95

Last Updated: 09/26/2026